Skip to main content
. 2023 Mar 3;11(3):773. doi: 10.3390/biomedicines11030773

Figure 2.

Figure 2

Current FDA-approved treatment agents for TNBC versus the drugs tested in and specific to TNBC patient-derived organoids.